LR HEALTH & BEAUTY SE ANNOUNCES SUCCESSFUL CONCLUSION OF THE WRITTEN PROCEDURE INITIATED ON 19 MAY 2026, FULLY SUBSCRIBED ISSUANCES OF SHARES AND BONDS, ...

LR HEALTH & BEAUTY SE ANNOUNCES SUCCESSFUL CONCLUSION OF THE WRITTEN PROCEDURE INITIATED ON 19 MAY 2026, FULLY SUBSCRIBED ISSUANCES OF SHARES AND BONDS, ADMISSION TO TRADING OF THE NEW BONDS AND REDEMPTION OF OUTSTANDING SUPER SENIOR BRIDGE BONDS

Ahlen, 5 June 2026 – On 19 May 2026, LR Health & Beauty SE (the “Company”) initiated a written procedure (the “Written Procedure”) among the holders of the Company’s 2024/2028 bonds (ISIN: NO0013149658) (the “Bondholders” and the “Bonds”) in accordance with the terms and conditions of the Bonds for the purpose of carrying out a comprehensive restructuring of the Bonds and the Company’s capital structure.

The deadline for voting in the Written Procedure was 15:00 hrs CEST today. Votes representing a sufficient part of the adjusted nominal amount of the Bonds were obtained in order to form a quorum and a requisite majority of the adjusted nominal amount voted in favour of the amendments and the waivers in the Written Procedure.

Jörg Körfer, CEO of LR Health & Beauty SE, states: “The successful completion of the Written Procedure, the full subscription of the new bond tranche, and the full subscription of the new equity shares represent significant milestones on our path to successfully strengthen the Company’s capital structure. In this regard, the strong confidence from our stakeholders lays the foundation for us to now consistently drive forward the strategic and operational initiatives aimed at restoring and securing sustainable growth for the LR Group.”

Effectiveness of the Written Procedure

The amendments and waivers approved in the Written Procedure are conditional upon satisfaction of the following conditions, which are expected to be satisfied on or prior to 11 June 2026:

• completion of the EUR 11,764,705.88 (cash proceeds of EUR 10,000,000) share issue in Abydos S.à r.l. (the “Share Issue” and the “Parent”) and entry into the investment and shareholders' agreement by all investors in the Share Issue;
• transfer of all shares in the Company and the receivable under an existing EUR 4,000,000 shareholder loan from the Company’s existing shareholder to the Parent;
• entry into the amended and restated terms and conditions for the Bonds; and
• entry into the terms and conditions for the EUR 27,500,000 junior bonds to be issued by the Parent (the “Junior Bonds”).

Full Subscription of the Share Issue and the New Bond Issue 

The Share Issue has been fully subscribed and is expected to be executed on 10 June 2026. The new bond issue of EUR 30,000,000 (total subscription price of EUR 10,000,000) under the amended and restated terms and conditions for the Bonds (the “New Bonds” and the “New Bond Issue”) has been fully subscribed and the New Bonds are expected to be issued on 17 June 2026. 

Admission to Trading 

The New Bonds are intended to be admitted to trading on the corporate bond list of Nasdaq Stockholm and listed on the Open Market of the Frankfurt Stock Exchange as soon as practically possible after the issue date of the New Bonds which is expected to be 17 June 2026.

The Junior Bonds are expected to be issued on 15 June 2026. The Junior Bonds shall be admitted to trading on the Open Market of the Frankfurt Stock Exchange within sixty (60) calendar days (with an intention of thirty (30) calendar days) of the issue date of the Junior Bonds, and on the Regulated Market of Nasdaq Stockholm (or another Regulated Market) within twelve (12) months of the issue date of the Junior Bonds.

Redemption of the Super Senior Bridge Bonds

The Company hereby gives notice to the holders of the Company’s super senior bridge bonds (ISIN: NO0013739029) issued by the Company on 26 March 2026 (the "Super Senior Bridge Bonds") of the redemption in full of the Super Senior Bridge Bonds on 22 June 2026. The redemption of the Super Senior Bridge Bonds is conditional upon the completion of the Share Issue and the New Bond Issue.

For further information regarding the Written Procedure and the restructuring measures set out therein, please refer to the notice of the Written Procedure which is accessible on the Company's website at https://ir.lrworld.com/en/bond/.


LR Group

Under the motto “More quality for your life”, the LR Group – headquartered in the town of Ahlen/Westphalia – successfully produces and distributes various high-quality nutritional supplements and cosmetic products in 32 countries. As an attractive Social Commerce Company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool “LR neo” offers the international partnership all business-relevant key figures and information for their LR business in one dashboard.

Since 1985, LR has been firmly established in the market as a “people business” with a focus on people and personal consultation. In times of changing working environments, the business model is particularly appealing to those who are looking for more flexibility, a better work-life balance and greater financial independence.

The processing of aloe vera has been one of LR’s core competencies for over 20 years. Only the leaf’s valuable inside is used for the products. In Ahlen, the company has built one of the most modern aloe vera production facilities for aloe vera drinking gels in Europe.

In the fall of 2009, LR founded the LR Global Kids Fund e.V., which supports disadvantaged children and their families in many countries around the world efficiently and without the usual red tape in cooperation with local institutions. For further information on our commitment to sustainability, please read our Sustainability Report.


Contact:

PR Contact:

LR Health & Beauty SE 
Almut Kellermeyer  
Head of Corporate Communication  
Kruppstraße 55 
59227 Ahlen 
Phone: +49(0)2382 7658-106
E-mail: a.kellermeyer@LRworld.com
https://ir.lrworld.com/

IR Contact:

cometis AG
Thorben Burbach
Friedrichstrasse 22
65185 Wiesbaden
Phone: +49(0)611 - 205855-23
Fax: +49(0)611 - 205855-66
E-mail: burbach@cometis.de